Consensus Meetings Regarding Uterine Artery Embolization and Focused Ultrasound in Fibroid Treatment: an Analysis Konsensusgespräche zu Uterusarterienembolisation und fokussier- tem Ultraschall in der Myombehandlung: eine Standortbestimmung

On 10/16/2005, gynecology and radiology specialists met in Berlin for a consensus meeting regarding the use of uterine artery embolization (UAE; fibroid embolization) to treat fibroids [1]. The goal of this meeting was to summarize the current state of knowledge regarding fibroid embolization, which was a new treatment option at that time, and to provide recommendations regarding indication, implementation and follow-up from an interdisciplinary radiological-gynecological standpoint. In 2010, representatives from Austria and Switzerland participated in the discussion for the first time so that consensus recommendations with the support of the professional societies can now be made across borders [2]. In 2013, the consensus meetings were expanded to include an interdisciplinary dialog regarding the use of MR-guided focused ultrasound (MRgFUS [3]) in the treatment of fibroids and have since then been held every two years at the IROS, the threecountry meeting of the German, Austrian, and Swiss societies for interventional radiology [4–7]. The current edition of RöFo [8, 9] presents the results of the 3rd consensus meeting “MRgFUS for fibroid treatment” and 6th consensus meeting “UAE for fibroid treatment” which was held on January 14, 2017. For the 3rd consensus meeting “MRgFUS for fibroid treatment”, a selective search of the literature including topics deemed relevant by the invited participants was performed. Selected publications were included in the appendix of the consensus paper. The effects of pretreatment with ulipristal acetate, the recommended interval between MRgFUS and trying to conceive, the approach in the case of postinterventional discharge of fibroid material from the vagina (fibroid expulsion), the necessity of fol-